Abiopharma

🔍 FIELD Robert C (Executive)

Company: FIRST US BANCSHARES, INC. (FUSB)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Acquired 3,300 shares of Common Stock, $.01 par value at $16.39 per share (Direct)
  Date: 2026-09-01 | Code: P | equity_swap_involved: false | shares_owned_after: 11,300.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 288 shares of Common Stock, $.01 par value at $16.4 per share (Direct)
  Date: 2026-09-02 | Code: P | equity_swap_involved: false | shares_owned_after: 11,588.00 | transaction_form_type: 4 | Footnotes: F2
• Holds 0 shares of Common Stock, $.01 par value (Direct)
  Date: 2026-09-01 | Code: H | shares_owned_after: 2,960.00

Footnotes:

• F1: This price represents the weighted average purchase price (rounded to the nearest cent) for multiple transactions reported on this line. The prices of the transactions reported on this line ranged from $16.35 to $16.40. Upon request by the Commission staff, the issuer or a security holder of the issuer, the reporting person will undertake to provide full information regarding the number of shares purchased at each separate price.
• F2: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.